| For: | Leowattana W, Leowattana T, Leowattana P. Circulating angiotensin converting enzyme 2 and COVID-19. World J Clin Cases 2022; 10(34): 12470-12483 [PMID: 36579082 DOI: 10.12998/wjcc.v10.i34.12470] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i34/12470.htm |
| Number | Citing Articles |
| 1 |
Murat Oz, Wassim Chehadeh, Omamah Alfarisi, Farhan S. Cyprian. Plasma ACE and ACE2 Levels Are Altered in Patients with COVID-19. Viruses 2026; 18(4): 465 doi: 10.3390/v18040465
|
| 2 |
Biwash Ghimire, Pradeep Giri, Susan Tavernier, Sarah E. Hobdey, Ali Aghazadeh-Habashi. Exploratory Analysis of Plasma Angiotensin-Converting Enzyme 2 and Angiotensin Peptides as Candidate Discriminatory Signals in Breast Cancer: A Pilot Case–Control Study. Biomedicines 2026; 14(5): 1086 doi: 10.3390/biomedicines14051086
|
| 3 |
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, Ioanna Dimopoulou, Anastasia Kotanidou, Stylianos E. Orfanos. Endotheliopathy in Acute COVID-19 and Long COVID. International Journal of Molecular Sciences 2023; 24(9): 8237 doi: 10.3390/ijms24098237
|
| 4 |
Maria A. Dobrynina, Aleksandr V. Zurochka, Mariia V. Komelkova, Vladimir A. Zurochka, Evgeny A. Praskurnichiy, Liana V. Ryabova, Alexey P. Sarapultsev. Alteration in innate immune cues assessed by analyzing peripheral blood immune system in post-covid patients. Russian Journal of Infection and Immunity 2023; 13(5): 864 doi: 10.15789/2220-7619-AII-9641
|
| 5 |
Yasmin K. Elsharabassi, Nuha T. Swaidan, Mohamed M. Emara. Potential Resistance Mechanisms Exhibited by Cystic Fibrosis Patients Against SARS-CoV-2. Viruses 2025; 17(7): 919 doi: 10.3390/v17070919
|